Literature DB >> 27902389

Antimicrobial susceptibility to azithromycin among Salmonella enterica Typhi and Paratyphi A isolates from India.

Richa Misra1, Kashi Nath Prasad1.   

Abstract

Decreased ciprofloxacin susceptibility (DCS) and multidrug resistance in typhoidal Salmonella isolates in areas of endemicity are significant therapeutic problems. Guidelines for azithromycin disc diffusion and MIC interpretive criteria for Salmonella enterica serovar Typhi were published recently by the Clinical and Laboratory Standards Institute in 2015. We investigated the antimicrobial susceptibility pattern of azithromycin in 100 isolates of Salmonella Typhi (n=80), Paratyphi A (n=18) and B (n=2) recovered from bloodstream infections from January 2013 to December 2015. Zone sizes were extrapolated against MIC values, and a scatter plot was constructed. The azithromycin MICs by Etest ranged from 2 to 16 µg ml-1, while the disc diffusion diameters were from 13 to 22 mm. We observed that the margin of the zone of inhibition around the azithromycin disc may not be very clear and therefore difficult to interpret and that there was wide variation in the zone sizes for the same MIC value in both serovars. DCS was observed in 85 % of Salmonella Typhi recovered (68/80) and in 15/18 (83.3 %) Paratyphi A isolates. Judicious use of azithromycin is advocated as an alternative oral agent in endemic areas where DCS is common.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27902389     DOI: 10.1099/jmm.0.000390

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  2 in total

1.  Azithromycin resistance mechanisms in typhoidal salmonellae in India: A 25 years analysis.

Authors:  Priyanka Sharma; Bhavana Kumari; Sushila Dahiya; Umay Kulsum; Sambuddha Kumar; Neelam Manral; Sangeeta Pandey; Punit Kaur; Seema Sood; Bimal Kumar Das; Arti Kapil
Journal:  Indian J Med Res       Date:  2019-03       Impact factor: 2.375

2.  Prevalence of Salmonella typhi in among febrile patients in a tertiary care hospital of South West Rajasthan.

Authors:  Upasana Bhumbla; Parul Chaturvedi; Sarita Jain
Journal:  J Family Med Prim Care       Date:  2022-06-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.